Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Charles River Laboratories

18 Giant U.S. Stocks At Most Risk From Trump's Tariff Tantrum

It's unclear if President Trump is just toying around with the threat of tariffs. But it's not fun for large U.S. companies in the S&P 500.

Investors Business Daily

Charles River Laboratories' Q3 2024 Earnings: What to Expect

Charles River Laboratories' Q3 2024 Earnings: What to Expect

Charles River Laboratories is expected to announce its third-quarter results next month, and analysts predict a double-digit decline in the company’s bottom-line figure.

Is Charles River Laboratories Stock Underperforming the Dow?

Is Charles River Laboratories Stock Underperforming the Dow?

Charles River Laboratories underperformed the Dow recently, but Wall Street analysts remain moderately optimistic about the stock’s prospects.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Charles River Labs Plummets 14% On 'Bleaker' Expectations For 2024

Charles River Laboratories slashed its outlook for 2024 due to light pharma demand, and CRL stock plummeted in early trades.

Investors Business Daily

Charles River Laboratories Earnings Preview: What to Expect

Charles River Laboratories is poised to release its second-quarter earnings next month, and analysts expect a double-digit earnings dip.

Ten Big Losers To Start The Year. Tesla Isn't The Worst.

The S&P 500 index is up slightly in 2024, but many components are big losers, including Dow Jones giant Boeing and Tesla.

Investors Business Daily

Stocks Settle Mixed as 10-Year T-note Yield Stays Above 4%

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.42%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.17%. Stocks on Tuesday settled mixed. Reduced expectations for...

inkl

Read news from The Economist, FT, and more,
with one subscription

Coastal biomedical labs are bleeding more horseshoe crabs with little accountability

Coastal biomedical labs are bleeding more horseshoe crabs with little accountability

Horseshoe crab blood is used to test vaccines around the world. But while Europe has approved a synthetic alternative, biomedical labs are bleeding more crabs from the Atlantic Coast.

Charles River Tumbles As DOJ, PETA Zero In On Monkey Shipments

Charles River Tumbles As DOJ, PETA Zero In On Monkey Shipments

Charles River Laboratories announced a shortfall in monkey shipments on Wednesday that weighed on its 2023 outlook, and CRL stock toppled.

Investors Business Daily

Does Charles River Laboratories International Deserve a Place in Your Portfolio?

Does Charles River Laboratories International Deserve a Place in Your Portfolio?

The shares of Charles River Laboratories (CRL) have plunged in price despite the company’s solid results. So, can they rebound by the company leveraging its broad portfolio of products and services? Read on. Let’s find out.

People

Elizabeth Anderson

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

British Airways

the Wall Street Journal

SP Global Market Intelligence

Norwegian Cruise Line

Walgreens Boots Alliance

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

249,657 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play